Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DYNAVAX TECHNOLOGIES CORP Director's Dealing 2021

Feb 23, 2021

32130_dirs_2021-02-23_bd6ad578-fe8d-47b6-9905-fa8189de9c9b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DYNAVAX TECHNOLOGIES CORP (DVAX)
CIK: 0001029142
Period of Report: 2021-02-22

Reporting Person: Spencer Ryan (Director, CEO and Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-02-22 Common Stock A 1519 $3.39 Acquired 59578 Direct
2021-02-22 Common Stock M 20833 Acquired 80411 Direct
2021-02-22 Common Stock F 10791 $9.60 Disposed 69620 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-02-22 Restricted Stock Unit $ M 20833 Disposed Common Stock (20833) Direct

Footnotes

F1: Includes 1,519 shares acquired under Issuer's 2014 Employee Stock Purchase Plan (ESPP) on February 12, 2021.

F2: Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 22, 2019.

F3: The reporting person is reporting the withholding by Dynavax Technologies Corporation of 10,791 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the delivery of common stock to the reporting person on February 22, 2021.